ValiRx plc (VAL.L)
Develops cancer drugs and diagnostic tests using peptide technology.
0.16+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-73.3%
The outlook
ValiRx is trading near its 52-week low at 0.16p, well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst coverage appears minimal or unavailable. Current price action reflects sustained weakness with little near-term momentum evident.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Market cap
$2.1M
52-wk high
0.85
52-wk low
0.13
50-day avg
0.17
200-day avg
0.29
Trailing P/E
—